naproxen has been researched along with ergotamine in 15 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (ergotamine) | Trials (ergotamine) | Recent Studies (post-2010) (ergotamine) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 2,352 | 103 | 103 |
| Protein | Taxonomy | naproxen (IC50) | ergotamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.056 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 6.499 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 3.16 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 2.761 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 4.142 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0021 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0043 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0038 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.012 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0008 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 1.728 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.064 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.049 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0065 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.056 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0008 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0043 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0035 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Korczyn, AD; Streiffler, M; Treves, TA | 1 |
| Pradalier, A; Vincent, D | 1 |
| Saadah, HA | 1 |
| Hering, R; Steiner, TJ | 1 |
| Baumel, B; Diamond, S; Eisner, LS; Peters, K; Saper, JR; Sargent, JD; Solbach, P | 1 |
| Mathew, NT | 1 |
| Mathew, N | 1 |
| Tfelt-Hansen, P | 1 |
| Dordain, G; Dry, J; Pradalier, A; Rancurel, G; Rascol, A; Verdure, L | 1 |
| Damasio, H | 1 |
| Morillo, LE | 2 |
4 review(s) available for naproxen and ergotamine
| Article | Year |
|---|---|
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
Drug management of adult vascular headaches (migraine and cluster headache): Part II--Prevention and attacks.
Topics: Adult; Amitriptyline; Belladonna Alkaloids; Cluster Headache; Cyproheptadine; Drug Combinations; Ergotamine; Ergotamines; Female; Humans; Lithium; Lithium Carbonate; Male; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Naproxen; Phenobarbital; Pregnancy; Pregnancy Complications; Propranolol; Vascular Headaches | 1984 |
Migraine headache.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Diclofenac; Drug Therapy, Combination; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2003 |
Migraine headache.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Ergotamine; Humans; Ibuprofen; Indoles; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Oxazolidinones; Piperidines; Pyrrolidines; Salicylates; Sumatriptan; Triazoles; Tryptamines | 2004 |
6 trial(s) available for naproxen and ergotamine
| Article | Year |
|---|---|
Naproxen sodium versus ergotamine tartrate in the treatment of acute migraine attacks.
Topics: Acute Disease; Double-Blind Method; Ergotamine; Humans; Migraine Disorders; Naproxen | 1992 |
[Migraine and non-steroidal anti-inflammatory agents].
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diclofenac; Ergotamine; Flufenamic Acid; Flurbiprofen; Humans; Metoclopramide; Migraine Disorders; Naproxen; ortho-Aminobenzoates; Randomized Controlled Trials as Topic | 1992 |
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.
Topics: Adult; Amitriptyline; Analgesics; Caffeine; Ergotamine; Evaluation Studies as Topic; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Outpatients; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine.
Topics: Adolescent; Adult; Caffeine; Clinical Trials as Topic; Drug Combinations; Ergotamine; Ergotamines; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen | 1988 |
Amelioration of ergotamine withdrawal symptoms with naproxen.
Topics: Adult; Clinical Trials as Topic; Ergotamine; Female; Headache; Humans; Male; Middle Aged; Naproxen; Promethazine; Substance Withdrawal Syndrome | 1987 |
Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartrate compound.
Topics: Acute Disease; Adult; Clinical Trials as Topic; Drug Tolerance; Ergotamine; Ergotamines; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen | 1985 |
6 other study(ies) available for naproxen and ergotamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine.
Topics: Adult; Caffeine; Drug Combinations; Ergotamine; Humans; Metoclopramide; Middle Aged; Migraine Disorders; Naproxen; Retrospective Studies | 1992 |
Still more on ergotamine withdrawal.
Topics: Ambulatory Care; Ergotamine; Humans; Naproxen; Substance Withdrawal Syndrome | 1987 |
Tolerability of naproxen sodium.
Topics: Acute Disease; Ergotamine; Humans; Migraine Disorders; Naproxen | 1986 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |